You are here

Increasing Hepatitis C Testing, Treatment, and Cure in People Living with HIV

May 2018


The Health Resources and Services Administration’s (HRSA) Ryan White HIV/AIDS Program (RWHAP) has had a long-standing commitment to people living with HIV (PLWH) who are coinfected with Hepatitis C. Despite advances in HIV treatment resulting in near-normal life expectancy for PLWH, those who are coinfected with HIV and Hepatitis C virus (HCV) still have a high risk of liver-related illness and death. Among people living with HIV, approximately 25% are coinfected. Viral hepatitis progresses faster and causes more liver-related health problems among people with HIV than among those who do not have HIV.

Recent scientific advances and improvements in health care make it possible to win the fight against viral hepatitis and save lives.  A simple blood test can detect viral hepatitis infection years before symptoms develop, and the new FDA-approved treatment options for Hepatitis C are a game-changer in the field of Hepatitis C care and treatment. For the first time, persons infected with Hepatitis C can be cured with all-oral, once-daily treatment regimens that last 12-24 weeks and have minimal side effects.

HRSA/HAB Resources


Clinician-to-Clinician Consultation

Slides, Toolkits, Webinars


Pocket Guide

Additional Resources

Browse for More

Total views: 1,302